$ctmx
CytomX Therapeutics sees a massive surge in social engagements, up 1359% driven by discussions around Varseta-M for CRC and upcoming CX-801 Melanoma results. However, critical attention is focused on the CX-2051 Phase [--] update with concerns about efficacy and past patient death.
About $ctmx
CytomX Therapeutics is a biopharmaceutical company focused on developing cancer therapies.
Insights
- $ctmx engagements is up 1359.12% from the previous week.
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [-----] +1,359%
[--] Month: [-------] +56%
[--] Months: [---------] -24%
[--] Year: [---------] +46%
1-Year High: [-------] on 2025-06-05
1-Year Low: [--] on 2025-04-19
Engagements by network (24h): X: [-----] Reddit: [--] YouTube: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [---] on 2025-11-12
1-Year Low: [--] on 2025-04-22
Mentions by network (24h): X: [--] Reddit: [--] YouTube: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $ctmx in the last [--] hours which is down 8.90% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-05-14
1-Year Low: [--] on 2025-04-22
The most influential creators that mention $ctmx in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @anthonystaj | [--] | [-----] | [--] | [-----] |
| @BOSSTRADING0 | [--] | [-----] | [--] | [---] |
| @stocket_rocket | [--] | [--] | [--] | [--] |
| @GuzmanAlic16045 | [--] | [--] | [--] | [--] |
| @BigChodu | [--] | [-----] | [--] | [--] |
| @CharlieQuiTrade | [--] | [--] | [--] | [--] |
| @Rakufl47519 | [--] | [--] | [--] | [--] |
| @anexpertone | [--] | [--] | [--] | [--] |
| @BuyTheUgly | [--] | [-----] | [--] | [--] |
| @Etere | [--] | [--] | [--] | [--] |
Sentiment: 90%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 90%
Daily Average: 86%
[--] Week: 100% no change
[--] Month: 92% +4%
[--] Months: 92% -8%
[--] Year: 92% +42%
1-Year High: 100% on 2025-02-18
1-Year Low: 33% on 2025-12-03
Most Supportive Themes:
- Varseta-M for CRC: (20%) CytomX is advancing Varseta-M, a potential first-in-class ADC, towards a registrational study in late-line Colorectal Cancer (CRC).
- CX-801 Melanoma Results: (10%) CytomX announced upcoming presentation of Phase [--] Melanoma results for CX-801.
Most Critical Themes:
- CX-2051 Phase [--] Update: (30%) All eyes are on the CX-2051 Phase [--] update in Q1, with potential concerns regarding small sample size efficacy numbers and a past patient death.
Top $ctmx Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"i want to add that this one is really the tale of whether tolerability can hold up. the ph1 early look showed some amazing results like a 100% response on a 10L patient. but the GI issues are no joke. i'm not sure loperamide is going to do much alone. would have rather seen rifaximin with it i've been meaning to say it. i like $CTMX. nice molecule. might say more later i've been meaning to say it. i like $CTMX. nice molecule. might say more later"
X Link @anthonystaj 2026-02-12T14:29Z [----] followers, [----] engagements
"i've been meaning to say it. i like $CTMX. nice molecule. might say more later"
X Link @anthonystaj 2026-02-12T02:47Z [----] followers, 13.6K engagements
"NEW YEAR NEW OPPORTUNITY Closed our [----] with +82% in biotech portfolio. 2026s goal is at least 100% return January pretty modest month in the biotech portfolio January +1.79% Notable winners in January $CMPS $TARA $QURE $REPL. Thanks for those whove followed me on this journey last year. ❤ $XBI $IBB GOAL ACHIEVED December in the books +10.88% for the month and +82.19% YTD. Honestly blessed and grateful for An amazing year. Notable winners $ABVX $ANNX $KOD $EWTX $CMPS $OVID $CTMX $IPSC $VTYX $UNH $ERAS $GANX. Getting better everyday ❤ thanks to all the amazing people and"
X Link @BOSSTRADING0 2026-02-07T19:19Z [----] followers, [----] engagements
"GOAL ACHIEVED December in the books +10.88% for the month and +82.19% YTD. Honestly blessed and grateful for An amazing year. Notable winners $ABVX $ANNX $KOD $EWTX $CMPS $OVID $CTMX $IPSC $VTYX $UNH $ERAS $GANX. Getting better everyday ❤ thanks to all the amazing people and community at BOSS and BioX. Dec +10.88% NOV +4% OCT +11% SEPT +7% August +13% July +16% NOV in the books +4% for the month vs SPX +0.4%. Thanks to primarily Biotech plays in $EWTX $JANX $ANVS $VTYX $ALT $CGEM $AVGO posted on my timeline . $SPX $SPY SHOUT OUT OUR AMAZING BOSSTRADING GROUP GOAL +80% in portfolio by YE NOV"
X Link @undefined 2025-12-25T15:59Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing